Get started
Author

David Sahner

Immunologic and Virologic Effects of Subcutaneous Interleukin 2 in Combination With Antiretroviral Therapy
2000 · Richard T. Davey Jr, Robert L. Murphy, et al. · JAMA · 173
Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes
2022 · Justin T. Reese, Hannah Blau, et al. · EBioMedicine · 169
PDF
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
2022 · Thomas L. Holland, Adit A. Ginde, et al. · The Lancet Respiratory Medicine · 123
PDF
A Randomized, Partially Blinded Phase 2 Trial of Antiretroviral Therapy, HIV‐Specific Immunizations, and Interleukin‐2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024)
2006 · J. Michael Kilby, R. Pat Bucy, et al. · The Journal of Infectious Diseases · 80
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60
PDF
Interleukin‐2 Increases CD4+Lymphocyte Numbers but Does Not Enhance Responses to Immunization: Results of A5046s
2003 · Hernan Valdez, Ronald Mitsuyasu, et al. · The Journal of Infectious Diseases · 55
Assessing the effect of selective serotonin reuptake inhibitors in the prevention of post-acute sequelae of COVID-19
2024 · Hythem Sidky, Kristen A. Hansen, et al. · Computational and Structural Biotechnology Journal · 31
PDF
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31
PDF
Data quality considerations for evaluating COVID-19 treatments using real world data: learnings from the National COVID Cohort Collaborative (N3C)
2023 · Hythem Sidky, Jessica C. Young, et al. · BMC Medical Research Methodology · 29
PDF
Generalizable Long COVID Subtypes: Findings from the NIH N3C and RECOVER Programs
2022 · Justin T. Reese, Hannah Blau, et al. · medRxiv · 28
PDF
Metformin is associated with reduced COVID-19 severity in patients with prediabetes
2022 · Lauren E. Chan, Elena Casiraghi, et al. · Diabetes Research and Clinical Practice · 20
PDF
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15
PDF
Preexisting Autoimmunity Is Associated With Increased Severity of Coronavirus Disease 2019: A Retrospective Cohort Study Using Data From the National COVID Cohort Collaborative (N3C)
2023 · Arjun S Yadaw, David K Sahner, et al. · Clinical Infectious Diseases · 12
PDF
Paxlovid (nirmatrelvir/ritonavir) effectiveness against hospitalization and death in N3C: A target trial emulation study
2023 · Kristen Hansen, Steve R. Makkar, et al. · medRxiv · 10
PDF
(210) Results from a phase I, double-blind, randomized, placebo-controlled, multiple-dose study evaluating the safety, tolerability, and pharmacokinetics of oral doses of NKTR-118
2008 · D. Sahner, H. van Paaschen, et al. · Journal of Pain · 7
Influence of Prior SARS-CoV-2 Infection on COVID-19 Severity: Evidence from the National COVID Cohort Collaborative
2023 · Nathaniel Hendrix, Hythem Sidky, et al. · medRxiv · 6
PDF
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19
2023 · Tomas O Jensen, Greg A Grandits, et al. · The Journal of Infectious Diseases · 4
PDF
Tixagevimab/Cilgavimab for Treatment of Hospitalised COVID-19 Patients: A Randomised, Double-Blind, Phase 3 Trial
2022 · Thomas L. Holland, Adit A. Ginde, et al. · SSRN Electronic Journal · 3
578. Metformin reduces the risk of Long COVID or Death over 6 months in an Emulated Target Trial of Primarily Omicron-infected Adults without Diabetes or Prediabetes: a New-User, Active-Comparator Analysis Using the National COVID Cohort Collaborative (N3C) Electronic Health Record Database. This research was supported in part by the Intramural/Extramural research program of the National Center for Advancing Translational Science, NIH
2025 · Carolyn Bramante, Til Sturmer, et al. · Open Forum Infectious Diseases · 2
Artificial Intelligence: Emerging Applications in Biotechnology and Pharma
2020 · David Sahner, David C. Spellmeyer · Elsevier eBooks · 2
Raw Perception, Phenomenal Experience, and Selfhood in Stevens' Poetry: What We May Learn from a Contemporary Scientific Theory of Consciousness
2013 · David Sahner · ˜The œWallace Stevens journal · 2
Human Consciousness and Selfhood: Potential Underpinnings and Compatibility with Artificial Complex Systems
2010 · David Sahner · Journal of consciousness exploration & research · 2
A Randomized, Placebo-Controlled, Dose-Escalation, Phase 1 Study of the Safety and Pharmacokinetics of Amphotericin B Inhalation Powder in Healthy Subjects.
2007 · Annette Marcantonio, Alan R. Kugler, et al. · Blood · 2
Metformin at the time of Covid-19 infection and risk of Long Covid: A Target Trial Emulation Study
2025 · Carolyn Bramante, John B Buse, et al. · 1
PDF
Clinical Decision Support Using a Partially Instantiated Probabilistic Graphical Model Optimized Through Quantum Annealing: Proof-of-Concept of a Computational Method Using a Clinical Data Set
2021 · David K. Sahner, Richard J. Williams · SSRN Electronic Journal · 1
Works count: 34
Citation count: 869
H-index: 12
I10-index: 14
Year
Topic
Type